Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1929758114;58115;58116 chr2:178594605;178594604;178594603chr2:179459332;179459331;179459330
N2AB1765653191;53192;53193 chr2:178594605;178594604;178594603chr2:179459332;179459331;179459330
N2A1672950410;50411;50412 chr2:178594605;178594604;178594603chr2:179459332;179459331;179459330
N2B1023230919;30920;30921 chr2:178594605;178594604;178594603chr2:179459332;179459331;179459330
Novex-11035731294;31295;31296 chr2:178594605;178594604;178594603chr2:179459332;179459331;179459330
Novex-21042431495;31496;31497 chr2:178594605;178594604;178594603chr2:179459332;179459331;179459330
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACT
  • RefSeq wild type template codon: TGA
  • Domain: Fn3-28
  • Domain position: 14
  • Structural Position: 16
  • Q(SASA): 0.2318
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/I None None 0.032 N 0.324 0.306 0.342865806769 gnomAD-4.0.0 1.59534E-06 None None None None N None 0 0 None 0 0 None 0 0 0 1.43786E-05 0
T/S None None 0.153 N 0.198 0.143 0.144782658237 gnomAD-4.0.0 1.59529E-06 None None None None N None 0 0 None 0 0 None 0 0 2.8659E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.2229 likely_benign 0.2345 benign -0.572 Destabilizing 0.489 N 0.509 neutral N 0.476273991 None None N
T/C 0.6888 likely_pathogenic 0.6867 pathogenic -0.498 Destabilizing 0.998 D 0.516 neutral None None None None N
T/D 0.4565 ambiguous 0.4795 ambiguous -1.145 Destabilizing 0.956 D 0.465 neutral None None None None N
T/E 0.5473 ambiguous 0.577 pathogenic -1.138 Destabilizing 0.956 D 0.489 neutral None None None None N
T/F 0.6721 likely_pathogenic 0.6726 pathogenic -0.696 Destabilizing 0.956 D 0.566 neutral None None None None N
T/G 0.2277 likely_benign 0.2358 benign -0.832 Destabilizing 0.86 D 0.55 neutral None None None None N
T/H 0.4918 ambiguous 0.5053 ambiguous -1.238 Destabilizing 0.998 D 0.557 neutral None None None None N
T/I 0.7744 likely_pathogenic 0.7913 pathogenic 0.03 Stabilizing 0.032 N 0.324 neutral N 0.519181225 None None N
T/K 0.3842 ambiguous 0.3969 ambiguous -0.829 Destabilizing 0.956 D 0.475 neutral None None None None N
T/L 0.3089 likely_benign 0.3243 benign 0.03 Stabilizing 0.514 D 0.517 neutral None None None None N
T/M 0.2086 likely_benign 0.2202 benign 0.405 Stabilizing 0.988 D 0.523 neutral None None None None N
T/N 0.1825 likely_benign 0.1839 benign -0.953 Destabilizing 0.942 D 0.474 neutral N 0.499415825 None None N
T/P 0.854 likely_pathogenic 0.8677 pathogenic -0.139 Destabilizing 0.97 D 0.501 neutral D 0.53053753 None None N
T/Q 0.3732 ambiguous 0.3838 ambiguous -1.174 Destabilizing 0.978 D 0.505 neutral None None None None N
T/R 0.3798 ambiguous 0.3928 ambiguous -0.548 Destabilizing 0.978 D 0.515 neutral None None None None N
T/S 0.1209 likely_benign 0.1143 benign -1.045 Destabilizing 0.153 N 0.198 neutral N 0.496124804 None None N
T/V 0.6118 likely_pathogenic 0.6368 pathogenic -0.139 Destabilizing 0.514 D 0.52 neutral None None None None N
T/W 0.8913 likely_pathogenic 0.8946 pathogenic -0.725 Destabilizing 0.998 D 0.631 neutral None None None None N
T/Y 0.6841 likely_pathogenic 0.6828 pathogenic -0.433 Destabilizing 0.978 D 0.576 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.